UK firm gets grant for electronic DNA technology:
This article was originally published in Clinica
Executive Summary
The UK's LINK programme for Applied Genomics has awarded Molecular Sensing a £347,000 ($562,000) grant to develop clinical microbiology diagnostics based on the firm's electronic DNA detection system. The system, says the Wiltshire, UK company, is particularly advantageous where rapid diagnosis of a disease can significantly benefit the patient. For example, meningitis can prove fatal if undiagnosed and untreated in the first 72 hours. However, current methods involving microscopy or culturing of bacteria are slow, require significant expertise and are often inconclusive.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.